ORIC Pharmaceuticals Inc [ORIC] stock prices are up 3.37% to $12.88 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The ORIC shares have gain 4.72% over the last week, with a monthly amount drifted -7.40%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Ladenburg Thalmann started tracking the stock with Buy rating on July 08, 2025, and set its price target to $15. On October 31, 2024, Wells Fargo initiated with a Overweight rating and assigned a price target of $20 on the stock. Stifel started tracking the stock assigning a Buy rating and suggested a price target of $20 on September 06, 2024. Cantor Fitzgerald initiated its recommendation with a Overweight. Wedbush started tracking with a Outperform rating for this stock on September 22, 2023, and assigned it a price target of $8. In a note dated March 23, 2023, H.C. Wainwright upgraded a Buy rating on this stock but restated the target price of $16.
The stock price of ORIC Pharmaceuticals Inc [ORIC] has been fluctuating between $3.90 and $14.93 over the past year. Currently, Wall Street analysts expect the stock to reach $18 within the next 12 months. ORIC Pharmaceuticals Inc [NASDAQ: ORIC] shares were valued at $12.88 at the most recent close of the market. An investor can expect a potential return of 39.75% based on the average ORIC price forecast.
Analyzing the ORIC fundamentals
Gross Profit Margin for this corporation currently stands at -0.33% with Operating Profit Margin at -140.4%, Pretax Profit Margin comes in at -128.75%, and Net Profit Margin reading is -128.75%. To continue investigating profitability, this company’s Return on Assets is posted at -0.4, Equity is -0.52 and Total Capital is -0.46.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 12.31 points at the first support level, and at 11.75 for the second support level. However, for the 1st resistance point, the stock is sitting at 13.24, and for the 2nd resistance point, it is at 13.61.
Ratios To Look Out For
It’s worth pointing out that ORIC Pharmaceuticals Inc [NASDAQ:ORIC]’s Current Ratio is 16.13. On the other hand, the Quick Ratio is 16.13, and the Cash Ratio is 4.2.
Transactions by insiders
Recent insider trading involved Piscitelli Dominic, Chief Financial Officer, that happened on Oct 06 ’25 when 11000.0 shares were sold. PRESIDENT AND CEO, Chacko Jacob completed a deal on Oct 06 ’25 to sell 37461.0 shares. Meanwhile, Officer Dominic Piscitelli bought 50000.0 shares on Oct 06 ’25.
